Canada’s ‘SAME-DAY’ Euthanasia: Inside the Rapid Expansion of MAiD

Key Takeaways

• 16,500 Canadians died via MAiD in 2024.
• Over 200 same‑day euthanasias recorded in Ontario 2023.
• 30% of reviewed cases approved and executed same day.
• 2,200 providers performed MAiD; 100 did >30 deaths each.
• 2021 rule change removed 10‑day reflection period.

Summary

Canada’s Medical Assistance in Dying (MAiD) program recorded over 16,500 deaths in 2024, with a growing number of same‑day euthanasia cases. In Ontario alone, more than 200 individuals were approved and injected within 24 hours in 2023, and a provincial review found that roughly 30% of examined cases occurred on the day of approval. The 2021 removal of the 10‑day reflection period accelerated the process, allowing clinicians to act quickly when capacity loss is anticipated. Critics cite disputed consent and coercion in several high‑profile cases, raising questions about safeguards.

Pulse Analysis

Canada’s assisted‑dying framework has evolved into one of the world’s most extensive programs, driven by legislative shifts and rising public demand. After the 2021 amendment that eliminated the mandatory 10‑day reflection period, clinicians can now proceed with lethal injections once eligibility is confirmed, especially for patients at risk of losing decision‑making capacity. Federal data shows 16,500 MAiD deaths in 2024, while provincial audits reveal a surge in same‑day approvals, underscoring how policy changes translate into faster end‑of‑life outcomes.

The acceleration has sparked intense scrutiny over consent integrity. Cases like Mrs. B, who withdrew her request yet was euthanized hours later, and Mr. C, whose delirium was allegedly managed to secure a "yes," illustrate potential coercion and procedural lapses. Approximately 30% of the 219 cases examined occurred on the same day as approval, and over 2,200 health professionals participated in 2024, with a subset handling more than 30 procedures each. These figures highlight systemic vulnerabilities that could compromise vulnerable patients, especially those with disabilities or mental‑health challenges.

Looking ahead, the government’s plan to extend MAiD to individuals suffering solely from mental illness intensifies the debate. While proponents argue for broader autonomy, critics warn that safeguards have not kept pace with the program’s rapid growth. Policymakers may face pressure to reinstate waiting periods, tighten consent verification, and enhance oversight mechanisms. The trajectory of Canada’s MAiD system will likely influence international discussions on assisted suicide, shaping how other jurisdictions balance compassionate care with ethical safeguards.